Signal recognition particle
(Redirected from Docking protein)
Signal Recognition Particle (SRP) is a ribonucleoprotein that plays a critical role in the targeting and translocation of proteins to the endoplasmic reticulum (ER) membrane in eukaryotic cells and the plasma membrane in prokaryotic cells. This process is essential for the proper sorting and functioning of proteins within the cell. The SRP recognizes and binds to signal sequences of nascent polypeptides emerging from the ribosome, halting their translation temporarily. Subsequently, it directs the ribosome-nascent chain complex (RNC) to the ER in eukaryotes or the plasma membrane in prokaryotes through interaction with its receptor (SR).
Structure
The SRP consists of a small, highly conserved RNA molecule known as 7SL RNA and six protein components in eukaryotes (SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72). The structure and composition of SRP can vary among different organisms. In prokaryotes, the SRP may contain fewer protein components. The SRP54 (or Ffh in prokaryotes) protein is particularly important for the interaction with the signal sequence of the nascent polypeptide and the SRP receptor.
Function
The primary function of the SRP is to recognize and target specific proteins to the ER in eukaryotes or the plasma membrane in prokaryotes. This targeting is mediated by the recognition of a hydrophobic signal sequence located at the N-terminus of the nascent protein. Upon recognition, SRP binds to the ribosome and the nascent chain, pausing translation. This pause allows the SRP-ribosome-nascent chain complex to bind to the SRP receptor located on the ER or plasma membrane. Once bound, the signal sequence is inserted into a translocon channel, and translation resumes, allowing the nascent protein to be co-translationally translocated across the membrane.
Clinical Significance
Mutations or dysfunctions in the components of the SRP pathway can lead to diseases related to protein misfolding and mistargeting. For example, alterations in the SRP pathway have been implicated in neurodegenerative diseases and certain types of cancer. Understanding the SRP pathway is crucial for developing therapeutic strategies targeting these diseases.
Research Directions
Current research on the SRP focuses on elucidating the detailed mechanisms of its interaction with the ribosome, the nascent polypeptide, and the SRP receptor. Additionally, studies aim to understand how alterations in the SRP pathway contribute to disease and to explore potential therapeutic interventions that can modulate SRP function.
This article is a molecular or cell biology stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD